InMed Pharmaceuticals
Quarterly Financials
| Values in thousands | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|
Revenue | $1,304 | $1,274 | $1,110 | $1,260 |
Gross Profit | 576 | 177 | 460 | 491 |
EBITDA | -1,788 | -2,084 | -2,151 | -1,693 |
EBIT | -1,841 | -2,137 | -2,204 | -1,748 |
Net Income | -1,787 | -2,142 | -2,572 | -1,671 |
Net Change In Cash | 1,304 | 1,274 | 1,110 | 1,260 |
Free Cash Flow | 285 | -1,659 | -2,500 | -1,826 |
Cash | 11,122 | 4,679 | 3,417 | 5,583 |
Basic Shares | 975 | 1,095 | 706 | 620 |
Annual Financials
| Values in thousands | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-06-30 |
|---|---|---|---|---|
Revenue | $4,941 | $6,287 | $5,478 | $1,402 |
Gross Profit | 1,706 | 1,505 | 1,858 | 699 |
EBITDA | -7,703 | -10,298 | -10,310 | -17,098 |
EBIT | -7,916 | -11,124 | -11,099 | -17,757 |
Net Income | -8,160 | -10,497 | -10,528 | -23,948 |
Net Change In Cash | 4,941 | 6,287 | 5,478 | 1,402 |
Free Cash Flow | -5,700 | -6,995 | -7,445 | -15,622 |
Cash | 11,122 | 8,987 | 11,806 | 7,953 |
Basic Shares | 975 | 762 | 244 | 56 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-06-30 | -$1.20 |
2025-03-31 | -$1.93 |
2024-12-31 | -$3.64 |
2024-09-30 | -$0.21 |
